Skip to search form
Skip to main content
Semantic Scholar's Logo
Create Free Account
You are currently offline. Some features of the site may not work correctly.
National Institutes of Health
Semantic Scholar uses AI to extract papers important to this topic.
Discovery of PAT-1102, a novel, potent and orally active histone deacetylase inhibitor with antitumor activity in cancer mouse models.
Sunil K Sukumaran
Corpus ID: 40083273
AIM Histone deacetylase (HDAC) inhibitors are a class of drugs that modulate transcriptional activity in cells and are known to…
Abstract 2051: PAT-1102, a novel HDAC inhibitor exhibits potent anti-tumor efficacy in patient-derived refractory solid tumors.
Pradip K. Majumder
Corpus ID: 72510689
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Histone deacetylases (HDAC) have been shown to be…
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE